Rank | Gene Set | Z-score |
---|---|---|
1 | positive regulation of gamma-delta T cell activation (GO:0046645) | 5.78641701 |
2 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 5.64439059 |
3 | * antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 5.61592695 |
4 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 5.50544143 |
5 | negative regulation of cell killing (GO:0031342) | 5.50544143 |
6 | negative T cell selection (GO:0043383) | 5.46939555 |
7 | * antigen processing and presentation of endogenous antigen (GO:0019883) | 5.34930418 |
8 | * antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 5.32569742 |
9 | negative thymic T cell selection (GO:0045060) | 5.26693464 |
10 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.82480993 |
11 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 4.74526639 |
12 | positive T cell selection (GO:0043368) | 4.70089247 |
13 | positive thymic T cell selection (GO:0045059) | 4.62429505 |
14 | regulation of gamma-delta T cell differentiation (GO:0045586) | 4.42522245 |
15 | regulation of gamma-delta T cell activation (GO:0046643) | 4.32031729 |
16 | response to interleukin-15 (GO:0070672) | 4.31035431 |
17 | cellular response to interleukin-15 (GO:0071350) | 4.23427102 |
18 | T cell selection (GO:0045058) | 4.19708985 |
19 | T cell migration (GO:0072678) | 4.19432032 |
20 | thymic T cell selection (GO:0045061) | 4.07045787 |
21 | regulation of alpha-beta T cell proliferation (GO:0046640) | 4.04765599 |
22 | activated T cell proliferation (GO:0050798) | 3.90858792 |
23 | B cell receptor signaling pathway (GO:0050853) | 3.85533152 |
24 | regulation of regulatory T cell differentiation (GO:0045589) | 3.79605389 |
25 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 3.76883721 |
26 | negative regulation of T cell mediated immunity (GO:0002710) | 3.75442488 |
27 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.72154642 |
28 | response to type I interferon (GO:0034340) | 3.62624529 |
29 | positive regulation of granulocyte differentiation (GO:0030854) | 3.62037859 |
30 | cellular response to type I interferon (GO:0071357) | 3.60679207 |
31 | type I interferon signaling pathway (GO:0060337) | 3.60679207 |
32 | regulation of T cell mediated cytotoxicity (GO:0001914) | 3.57768939 |
33 | leukocyte aggregation (GO:0070486) | 3.52983587 |
34 | regulation of T cell tolerance induction (GO:0002664) | 3.50524548 |
35 | regulation of natural killer cell mediated immunity (GO:0002715) | 3.49294091 |
36 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 3.49294091 |
37 | regulation of B cell differentiation (GO:0045577) | 3.46318198 |
38 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 3.45836512 |
39 | positive regulation of B cell differentiation (GO:0045579) | 3.41770146 |
40 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.38756522 |
41 | tolerance induction (GO:0002507) | 3.38122221 |
42 | immunoglobulin mediated immune response (GO:0016064) | 3.36330023 |
43 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.33680091 |
44 | regulation of leukocyte mediated cytotoxicity (GO:0001910) | 3.26327040 |
45 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.22752842 |
46 | regulation of tolerance induction (GO:0002643) | 3.21019310 |
47 | positive regulation of leukocyte mediated cytotoxicity (GO:0001912) | 3.20312046 |
48 | antigen receptor-mediated signaling pathway (GO:0050851) | 3.19229887 |
49 | detection of other organism (GO:0098543) | 3.17988846 |
50 | interferon-gamma production (GO:0032609) | 3.17623595 |
51 | detection of bacterium (GO:0016045) | 3.16552776 |
52 | positive regulation of tolerance induction (GO:0002645) | 3.15829680 |
53 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 3.09834055 |
54 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.09700830 |
55 | cellular extravasation (GO:0045123) | 3.09060064 |
56 | T cell receptor signaling pathway (GO:0050852) | 3.08056022 |
57 | macrophage activation involved in immune response (GO:0002281) | 3.08012809 |
58 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 3.05802360 |
59 | negative regulation of interleukin-12 production (GO:0032695) | 3.04428930 |
60 | regulation of cell killing (GO:0031341) | 3.04177779 |
61 | positive regulation of natural killer cell mediated immunity (GO:0002717) | 3.04062648 |
62 | T cell costimulation (GO:0031295) | 3.03912428 |
63 | positive regulation by symbiont of host defense response (GO:0052509) | 3.03669227 |
64 | modulation by symbiont of host defense response (GO:0052031) | 3.03669227 |
65 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.03669227 |
66 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.03669227 |
67 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.03669227 |
68 | modulation by symbiont of host immune response (GO:0052553) | 3.03669227 |
69 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.03463541 |
70 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 3.02106494 |
71 | mast cell activation (GO:0045576) | 3.01693611 |
72 | lymphocyte costimulation (GO:0031294) | 2.99347181 |
73 | positive regulation of cell killing (GO:0031343) | 2.96724163 |
74 | regulation of isotype switching to IgG isotypes (GO:0048302) | 2.96333095 |
75 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.95371380 |
76 | regulation of antigen processing and presentation (GO:0002577) | 2.93523495 |
77 | cytidine deamination (GO:0009972) | 2.92482792 |
78 | cytidine metabolic process (GO:0046087) | 2.92482792 |
79 | cytidine catabolic process (GO:0006216) | 2.92482792 |
80 | positive regulation of antigen processing and presentation (GO:0002579) | 2.92344900 |
81 | regulation of alpha-beta T cell activation (GO:0046634) | 2.91519803 |
82 | defense response to protozoan (GO:0042832) | 2.90259454 |
83 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.89199344 |
84 | response to interferon-beta (GO:0035456) | 2.88773389 |
85 | NIK/NF-kappaB signaling (GO:0038061) | 2.88596345 |
86 | positive regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043372) | 2.86349828 |
87 | negative regulation of innate immune response (GO:0045824) | 2.85732327 |
88 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.85596771 |
89 | B cell mediated immunity (GO:0019724) | 2.85353746 |
90 | cellular response to exogenous dsRNA (GO:0071360) | 2.83742838 |
91 | T cell proliferation (GO:0042098) | 2.82548913 |
92 | positive regulation of alpha-beta T cell activation (GO:0046635) | 2.82153326 |
93 | dendritic cell chemotaxis (GO:0002407) | 2.81626280 |
94 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 2.81292793 |
95 | positive regulation of CD4-positive, alpha-beta T cell activation (GO:2000516) | 2.80949652 |
96 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 2.79385664 |
97 | positive regulation of defense response to virus by host (GO:0002230) | 2.79381201 |
98 | alpha-beta T cell activation (GO:0046631) | 2.77747295 |
99 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 2.77419202 |
100 | regulation of T cell mediated immunity (GO:0002709) | 2.76880358 |
Rank | Gene Set | Z-score |
---|---|---|
1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 7.38668029 |
2 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 5.75969682 |
3 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 5.46902553 |
4 | * IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 4.96673425 |
5 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.93075632 |
6 | RUNX_20019798_ChIP-Seq_JUKART_Human | 3.66292121 |
7 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.48989948 |
8 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 3.39049166 |
9 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.23352786 |
10 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.12514270 |
11 | * MYB_26560356_Chip-Seq_TH2_Human | 3.09932267 |
12 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.82139017 |
13 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.70774139 |
14 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.70370500 |
15 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.48917990 |
16 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.45662859 |
17 | MYB_26560356_Chip-Seq_TH1_Human | 2.45154095 |
18 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.38037561 |
19 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.30654402 |
20 | MAF_26560356_Chip-Seq_TH1_Human | 2.19142026 |
21 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.18829400 |
22 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.16172594 |
23 | * GATA3_27048872_Chip-Seq_THYMUS_Human | 2.13595369 |
24 | * SPI1_23547873_ChIP-Seq_NB4_Human | 2.09049390 |
25 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.04504765 |
26 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.02598453 |
27 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.98509091 |
28 | UTX_26944678_Chip-Seq_JUKART_Human | 1.96676854 |
29 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.92026224 |
30 | * GATA3_26560356_Chip-Seq_TH2_Human | 1.89265372 |
31 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.74709908 |
32 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.74499597 |
33 | * SPI1_23127762_ChIP-Seq_K562_Human | 1.67380743 |
34 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.66684021 |
35 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.66468504 |
36 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.64523281 |
37 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.60728798 |
38 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.57802631 |
39 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.55992257 |
40 | MYC_22102868_ChIP-Seq_BL_Human | 1.55226480 |
41 | MAF_26560356_Chip-Seq_TH2_Human | 1.49494269 |
42 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.49478509 |
43 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.48904252 |
44 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.38567876 |
45 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.38474950 |
46 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.38009782 |
47 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.35266872 |
48 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.34116354 |
49 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.30564623 |
50 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.28814284 |
51 | GATA1_22025678_ChIP-Seq_K562_Human | 1.27202068 |
52 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.26953875 |
53 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.26747715 |
54 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.26528989 |
55 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.24515323 |
56 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.23982165 |
57 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.20650091 |
58 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.17451913 |
59 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.14113774 |
60 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.12467212 |
61 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.10755214 |
62 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.10572619 |
63 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.08635108 |
64 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.08201000 |
65 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.06239750 |
66 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.05698596 |
67 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.04060117 |
68 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.03176827 |
69 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.02496349 |
70 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.01802385 |
71 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 0.98383153 |
72 | GATA1_19941826_ChIP-Seq_K562_Human | 0.95052572 |
73 | * GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.92462760 |
74 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.91185118 |
75 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.90362576 |
76 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.88972169 |
77 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.87844067 |
78 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.87121910 |
79 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.86189668 |
80 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.84634887 |
81 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.84599911 |
82 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.82331582 |
83 | GATA2_19941826_ChIP-Seq_K562_Human | 0.81133342 |
84 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.79335399 |
85 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.78108446 |
86 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.77306929 |
87 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.77226754 |
88 | GATA3_26560356_Chip-Seq_TH1_Human | 0.75476894 |
89 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.73301382 |
90 | * TAL1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.73191697 |
91 | KDM2B_26808549_Chip-Seq_DND41_Human | 0.72133961 |
92 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 0.70060837 |
93 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.69803382 |
94 | RUNX1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.66345014 |
95 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.66223745 |
96 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.65125606 |
97 | P300_27268052_Chip-Seq_Bcells_Human | 0.63901777 |
98 | * JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.63268953 |
99 | GATA3_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.62206601 |
100 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.62015308 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0001835_abnormal_antigen_presentation | 4.22220639 |
2 | MP0005671_abnormal_response_to | 3.92045908 |
3 | MP0003724_increased_susceptibility_to | 3.82133475 |
4 | MP0003763_abnormal_thymus_physiology | 3.55560432 |
5 | MP0003436_decreased_susceptibility_to | 3.48977555 |
6 | MP0000685_abnormal_immune_system | 3.45504017 |
7 | MP0001800_abnormal_humoral_immune | 3.16977050 |
8 | MP0005387_immune_system_phenotype | 3.03716309 |
9 | MP0001790_abnormal_immune_system | 3.03716309 |
10 | MP0005000_abnormal_immune_tolerance | 3.01214194 |
11 | MP0009785_altered_susceptibility_to | 2.92871142 |
12 | MP0002723_abnormal_immune_serum | 2.69138029 |
13 | MP0005025_abnormal_response_to | 2.62379055 |
14 | MP0002452_abnormal_antigen_presenting | 2.57195921 |
15 | MP0002148_abnormal_hypersensitivity_rea | 2.53889832 |
16 | MP0002420_abnormal_adaptive_immunity | 2.53818562 |
17 | MP0001819_abnormal_immune_cell | 2.51123671 |
18 | MP0006082_CNS_inflammation | 2.49736748 |
19 | MP0002419_abnormal_innate_immunity | 2.46021198 |
20 | MP0002166_altered_tumor_susceptibility | 2.33939206 |
21 | MP0010155_abnormal_intestine_physiology | 2.26849514 |
22 | MP0009333_abnormal_splenocyte_physiolog | 2.20883647 |
23 | MP0003300_gastrointestinal_ulcer | 2.18852564 |
24 | MP0002398_abnormal_bone_marrow | 2.09079104 |
25 | MP0002405_respiratory_system_inflammati | 2.07521050 |
26 | MP0003303_peritoneal_inflammation | 2.06191417 |
27 | MP0000716_abnormal_immune_system | 2.02138996 |
28 | MP0004947_skin_inflammation | 1.92315893 |
29 | MP0003866_abnormal_defecation | 1.86810612 |
30 | MP0001873_stomach_inflammation | 1.82609243 |
31 | MP0001533_abnormal_skeleton_physiology | 1.80062713 |
32 | MP0001845_abnormal_inflammatory_respons | 1.78971212 |
33 | MP0000689_abnormal_spleen_morphology | 1.77847548 |
34 | MP0002006_tumorigenesis | 1.76063403 |
35 | MP0005464_abnormal_platelet_physiology | 1.73377753 |
36 | MP0002138_abnormal_hepatobiliary_system | 1.70702743 |
37 | MP0000703_abnormal_thymus_morphology | 1.70240626 |
38 | MP0002722_abnormal_immune_system | 1.69852188 |
39 | MP0002396_abnormal_hematopoietic_system | 1.62603985 |
40 | MP0002429_abnormal_blood_cell | 1.57354114 |
41 | MP0000465_gastrointestinal_hemorrhage | 1.57094238 |
42 | MP0005310_abnormal_salivary_gland | 1.47337990 |
43 | MP0002933_joint_inflammation | 1.44617409 |
44 | MP0008469_abnormal_protein_level | 1.44255904 |
45 | MP0003191_abnormal_cellular_cholesterol | 1.39193806 |
46 | MP0003045_fibrosis | 1.31801369 |
47 | MP0003183_abnormal_peptide_metabolism | 1.31402109 |
48 | MP0004381_abnormal_hair_follicle | 1.29657688 |
49 | MP0002998_abnormal_bone_remodeling | 1.28228816 |
50 | MP0005360_urolithiasis | 1.21369838 |
51 | MP0000858_altered_metastatic_potential | 1.20881573 |
52 | MP0001853_heart_inflammation | 1.17997796 |
53 | MP0009764_decreased_sensitivity_to | 1.17956469 |
54 | MP0001851_eye_inflammation | 1.13146574 |
55 | MP0002009_preneoplasia | 1.12958513 |
56 | MP0008260_abnormal_autophagy | 1.05324574 |
57 | MP0003448_altered_tumor_morphology | 1.02983826 |
58 | MP0005166_decreased_susceptibility_to | 1.02584656 |
59 | MP0003172_abnormal_lysosome_physiology | 1.01369433 |
60 | MP0004883_abnormal_blood_vessel | 1.01260797 |
61 | MP0003828_pulmonary_edema | 0.98760769 |
62 | MP0005075_abnormal_melanosome_morpholog | 0.97262736 |
63 | MP0004808_abnormal_hematopoietic_stem | 0.97122851 |
64 | MP0009763_increased_sensitivity_to | 0.93965058 |
65 | MP0005164_abnormal_response_to | 0.93768219 |
66 | MP0000249_abnormal_blood_vessel | 0.88404766 |
67 | MP0001986_abnormal_taste_sensitivity | 0.87313567 |
68 | MP0000569_abnormal_digit_pigmentation | 0.87052380 |
69 | MP0000604_amyloidosis | 0.86482765 |
70 | MP0001663_abnormal_digestive_system | 0.84216025 |
71 | MP0009840_abnormal_foam_cell | 0.83960340 |
72 | MP0003252_abnormal_bile_duct | 0.81460129 |
73 | MP0005390_skeleton_phenotype | 0.76716277 |
74 | MP0002877_abnormal_melanocyte_morpholog | 0.69557194 |
75 | MP0009765_abnormal_xenobiotic_induced | 0.68004975 |
76 | MP0000015_abnormal_ear_pigmentation | 0.66808842 |
77 | MP0002019_abnormal_tumor_incidence | 0.66415896 |
78 | MP0005058_abnormal_lysosome_morphology | 0.65766053 |
79 | MP0003795_abnormal_bone_structure | 0.65550340 |
80 | MP0002136_abnormal_kidney_physiology | 0.63736264 |
81 | MP0000490_abnormal_crypts_of | 0.63519302 |
82 | MP0003075_altered_response_to | 0.61499049 |
83 | MP0002132_abnormal_respiratory_system | 0.61294412 |
84 | MP0005397_hematopoietic_system_phenotyp | 0.60198074 |
85 | MP0001545_abnormal_hematopoietic_system | 0.60198074 |
86 | MP0001765_abnormal_ion_homeostasis | 0.59174427 |
87 | MP0009278_abnormal_bone_marrow | 0.57944961 |
88 | MP0003806_abnormal_nucleotide_metabolis | 0.57678164 |
89 | MP0000609_abnormal_liver_physiology | 0.57474742 |
90 | MP0002139_abnormal_hepatobiliary_system | 0.57164520 |
91 | MP0003656_abnormal_erythrocyte_physiolo | 0.56291659 |
92 | MP0000343_altered_response_to | 0.55823927 |
93 | MP0005451_abnormal_body_composition | 0.55727775 |
94 | MP0004782_abnormal_surfactant_physiolog | 0.55478827 |
95 | MP0002277_abnormal_respiratory_mucosa | 0.54392735 |
96 | MP0003091_abnormal_cell_migration | 0.53366057 |
97 | MP0003690_abnormal_glial_cell | 0.53039880 |
98 | MP0002693_abnormal_pancreas_physiology | 0.51996727 |
99 | MP0009643_abnormal_urine_homeostasis | 0.50794126 |
100 | MP0005319_abnormal_enzyme/_coenzyme | 0.48869204 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Abnormality of T cell number (HP:0011839) | 5.38511030 |
2 | T lymphocytopenia (HP:0005403) | 5.29157822 |
3 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 4.82019663 |
4 | Eczematoid dermatitis (HP:0000976) | 4.52959766 |
5 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.38456317 |
6 | Autoimmune hemolytic anemia (HP:0001890) | 4.33394408 |
7 | Recurrent fungal infections (HP:0002841) | 4.27907694 |
8 | Abnormality of T cells (HP:0002843) | 4.23524176 |
9 | Myositis (HP:0100614) | 4.21505051 |
10 | Panhypogammaglobulinemia (HP:0003139) | 3.98053342 |
11 | Severe combined immunodeficiency (HP:0004430) | 3.87388479 |
12 | Retrobulbar optic neuritis (HP:0100654) | 3.82215777 |
13 | Optic neuritis (HP:0100653) | 3.82215777 |
14 | Recurrent cutaneous fungal infections (HP:0011370) | 3.80269053 |
15 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.80269053 |
16 | Orchitis (HP:0100796) | 3.79264307 |
17 | Recurrent viral infections (HP:0004429) | 3.78689056 |
18 | Recurrent abscess formation (HP:0002722) | 3.75394346 |
19 | Vasculitis (HP:0002633) | 3.72492565 |
20 | IgG deficiency (HP:0004315) | 3.71587992 |
21 | Recurrent bacterial skin infections (HP:0005406) | 3.71450757 |
22 | Meningitis (HP:0001287) | 3.68008161 |
23 | Pustule (HP:0200039) | 3.65005438 |
24 | Recurrent bronchitis (HP:0002837) | 3.61405214 |
25 | Agammaglobulinemia (HP:0004432) | 3.59882310 |
26 | Chronic diarrhea (HP:0002028) | 3.53833068 |
27 | Encephalitis (HP:0002383) | 3.53258228 |
28 | Abnormality of T cell physiology (HP:0011840) | 3.53161701 |
29 | Stomatitis (HP:0010280) | 3.51102290 |
30 | Eosinophilia (HP:0001880) | 3.48547762 |
31 | Abnormality of eosinophils (HP:0001879) | 3.47037489 |
32 | Spontaneous hematomas (HP:0007420) | 3.44744336 |
33 | Increased IgM level (HP:0003496) | 3.40842511 |
34 | Granulocytopenia (HP:0001913) | 3.40398135 |
35 | Autoimmune thrombocytopenia (HP:0001973) | 3.39581187 |
36 | Gastrointestinal infarctions (HP:0005244) | 3.38301055 |
37 | Pulmonary infiltrates (HP:0002113) | 3.37752096 |
38 | Mediastinal lymphadenopathy (HP:0100721) | 3.24819326 |
39 | Leukocytosis (HP:0001974) | 3.24562292 |
40 | Abnormality of B cell number (HP:0010975) | 3.21136867 |
41 | Recurrent skin infections (HP:0001581) | 3.14640443 |
42 | Abnormality of macrophages (HP:0004311) | 3.13573509 |
43 | Thyroiditis (HP:0100646) | 3.06839596 |
44 | Hemoptysis (HP:0002105) | 3.01663491 |
45 | Combined immunodeficiency (HP:0005387) | 3.01107768 |
46 | Inflammation of the large intestine (HP:0002037) | 2.90091107 |
47 | Keratoconjunctivitis sicca (HP:0001097) | 2.81701054 |
48 | Increased IgE level (HP:0003212) | 2.78770533 |
49 | Chronic obstructive pulmonary disease (HP:0006510) | 2.75270716 |
50 | Obstructive lung disease (HP:0006536) | 2.75270716 |
51 | Gastrointestinal inflammation (HP:0004386) | 2.75107070 |
52 | Colitis (HP:0002583) | 2.74588106 |
53 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.74023776 |
54 | Hypergammaglobulinemia (HP:0010702) | 2.64199697 |
55 | B lymphocytopenia (HP:0010976) | 2.64140451 |
56 | Lymphopenia (HP:0001888) | 2.63433778 |
57 | Keratoconjunctivitis (HP:0001096) | 2.63188749 |
58 | IgM deficiency (HP:0002850) | 2.61727338 |
59 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.60567579 |
60 | Chest pain (HP:0100749) | 2.59293789 |
61 | Hypochromic anemia (HP:0001931) | 2.58924122 |
62 | Pulmonary embolism (HP:0002204) | 2.54275986 |
63 | Hypoplasia of the thymus (HP:0000778) | 2.51783254 |
64 | Gastrointestinal stroma tumor (HP:0100723) | 2.49624824 |
65 | Gingivitis (HP:0000230) | 2.47632111 |
66 | Papilloma (HP:0012740) | 2.46536290 |
67 | Verrucae (HP:0200043) | 2.46536290 |
68 | Hematochezia (HP:0002573) | 2.42308738 |
69 | Urticaria (HP:0001025) | 2.38665666 |
70 | Epistaxis (HP:0000421) | 2.38369160 |
71 | Chronic otitis media (HP:0000389) | 2.37861703 |
72 | Stomach cancer (HP:0012126) | 2.36278470 |
73 | IgA deficiency (HP:0002720) | 2.35472178 |
74 | Prolonged bleeding time (HP:0003010) | 2.31750562 |
75 | Abnormality of the prostate (HP:0008775) | 2.28312435 |
76 | Arterial thrombosis (HP:0004420) | 2.27088513 |
77 | Joint swelling (HP:0001386) | 2.26962092 |
78 | Hypoproteinemia (HP:0003075) | 2.23810103 |
79 | Abnormality of the pleura (HP:0002103) | 2.23440173 |
80 | Gingival bleeding (HP:0000225) | 2.22170537 |
81 | Lymphoma (HP:0002665) | 2.21281784 |
82 | Cellulitis (HP:0100658) | 2.19470167 |
83 | Osteomyelitis (HP:0002754) | 2.16198148 |
84 | Premature loss of primary teeth (HP:0006323) | 2.13911924 |
85 | Gangrene (HP:0100758) | 2.10264407 |
86 | Hypochromic microcytic anemia (HP:0004840) | 2.06591007 |
87 | Microcytic anemia (HP:0001935) | 2.05692668 |
88 | Alveolar cell carcinoma (HP:0006519) | 2.03816778 |
89 | Bronchitis (HP:0012387) | 2.02548091 |
90 | Skin rash (HP:0000988) | 2.00468994 |
91 | Anorexia (HP:0002039) | 1.96075870 |
92 | Neoplasm of the tracheobronchial system (HP:0100552) | 1.93512425 |
93 | Recurrent sinusitis (HP:0011108) | 1.93385802 |
94 | Restrictive lung disease (HP:0002091) | 1.91490773 |
95 | Skin ulcer (HP:0200042) | 1.89306374 |
96 | Dysostosis multiplex (HP:0000943) | 1.88462707 |
97 | Sepsis (HP:0100806) | 1.88458217 |
98 | Glomerulopathy (HP:0100820) | 1.88035490 |
99 | Viral hepatitis (HP:0006562) | 1.83096998 |
100 | Polyneuropathy (HP:0001271) | 1.81032457 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MAP4K1 | 4.24668630 |
2 | TXK | 3.90440577 |
3 | TAOK3 | 3.49604482 |
4 | TYK2 | 2.77522592 |
5 | RIPK4 | 2.72335300 |
6 | IRAK4 | 2.59822260 |
7 | MAP3K14 | 2.39284272 |
8 | FES | 2.36256101 |
9 | KIT | 2.32380360 |
10 | IKBKE | 2.29405344 |
11 | JAK1 | 2.29081899 |
12 | JAK3 | 2.26816729 |
13 | ITK | 2.20973507 |
14 | GRK6 | 2.13243810 |
15 | ZAP70 | 2.12697132 |
16 | BTK | 2.08484309 |
17 | SYK | 2.04450115 |
18 | ERN1 | 2.02586023 |
19 | BLK | 1.98213427 |
20 | TEC | 1.94963102 |
21 | CSK | 1.86564810 |
22 | TBK1 | 1.74317644 |
23 | MAP3K13 | 1.74134117 |
24 | PRPF4B | 1.70498822 |
25 | MAP2K3 | 1.56293778 |
26 | LCK | 1.53952063 |
27 | FGFR4 | 1.51394796 |
28 | HCK | 1.46594226 |
29 | IKBKB | 1.45828012 |
30 | FGFR3 | 1.44963901 |
31 | PIK3CG | 1.34218228 |
32 | NLK | 1.33161702 |
33 | TGFBR2 | 1.32360334 |
34 | LYN | 1.30995935 |
35 | CSF1R | 1.27577754 |
36 | EPHB1 | 1.18762575 |
37 | CAMKK2 | 1.16555043 |
38 | TRPM7 | 1.12647280 |
39 | MARK3 | 1.11912975 |
40 | IRAK1 | 1.09774014 |
41 | BMPR2 | 1.09415186 |
42 | MAP3K10 | 1.06819890 |
43 | JAK2 | 1.05155580 |
44 | PRKCQ | 0.98372185 |
45 | TLK1 | 0.98186663 |
46 | HIPK2 | 0.96327981 |
47 | MAPK7 | 0.95083063 |
48 | TNK2 | 0.91512630 |
49 | MAPK11 | 0.91355208 |
50 | STK10 | 0.86292593 |
51 | FRK | 0.86189718 |
52 | EPHA3 | 0.84948109 |
53 | ACVR1B | 0.84871132 |
54 | KDR | 0.84167354 |
55 | TESK2 | 0.82347977 |
56 | GRK7 | 0.80364081 |
57 | PIM1 | 0.80280107 |
58 | CDC42BPA | 0.78893105 |
59 | SCYL2 | 0.77574025 |
60 | NEK9 | 0.76804316 |
61 | PDK1 | 0.72376172 |
62 | MAP2K2 | 0.68642195 |
63 | MAP3K3 | 0.67568907 |
64 | MATK | 0.67018746 |
65 | MAP2K6 | 0.58745841 |
66 | PIK3CA | 0.58612856 |
67 | MAPK12 | 0.56675035 |
68 | FGR | 0.54867771 |
69 | CDK4 | 0.51866111 |
70 | CHUK | 0.47217646 |
71 | MAP3K1 | 0.46382255 |
72 | FYN | 0.45275437 |
73 | ADRBK2 | 0.42934532 |
74 | CAMKK1 | 0.42724053 |
75 | MAPKAPK2 | 0.42704555 |
76 | PTK2B | 0.42567588 |
77 | SIK3 | 0.41946820 |
78 | PRKCH | 0.41396625 |
79 | CDK6 | 0.38576189 |
80 | ABL1 | 0.37279184 |
81 | MAP3K11 | 0.37057162 |
82 | PDPK1 | 0.36629540 |
83 | IGF1R | 0.35701945 |
84 | NUAK1 | 0.35691318 |
85 | MAP3K7 | 0.34776553 |
86 | MST1R | 0.34247220 |
87 | PDGFRB | 0.33114080 |
88 | SGK3 | 0.32684613 |
89 | RIPK1 | 0.31773065 |
90 | MELK | 0.30853864 |
91 | PRKD2 | 0.30764347 |
92 | MAP3K2 | 0.30084358 |
93 | SGK2 | 0.29114280 |
94 | EIF2AK3 | 0.27171819 |
95 | GRK5 | 0.26196769 |
96 | CDK19 | 0.25762387 |
97 | RET | 0.25677127 |
98 | MAPK3 | 0.25561981 |
99 | EGFR | 0.23423824 |
100 | MAPKAPK3 | 0.23374435 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Primary immunodeficiency_Homo sapiens_hsa05340 | 3.86900054 |
2 | Graft-versus-host disease_Homo sapiens_hsa05332 | 3.56510193 |
3 | Allograft rejection_Homo sapiens_hsa05330 | 3.48209408 |
4 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 3.25130800 |
5 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.92408293 |
6 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.61187069 |
7 | Leishmaniasis_Homo sapiens_hsa05140 | 2.55997010 |
8 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 2.54020279 |
9 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.47274965 |
10 | Asthma_Homo sapiens_hsa05310 | 2.42722460 |
11 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 2.32546444 |
12 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.26759373 |
13 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.26303200 |
14 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 2.16261263 |
15 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 2.15245210 |
16 | Measles_Homo sapiens_hsa05162 | 2.10131246 |
17 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.01873855 |
18 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.94473033 |
19 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.91278647 |
20 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.76467002 |
21 | Viral myocarditis_Homo sapiens_hsa05416 | 1.72171309 |
22 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.67969023 |
23 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.61899735 |
24 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.56057309 |
25 | Influenza A_Homo sapiens_hsa05164 | 1.53737066 |
26 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.53210671 |
27 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.50868818 |
28 | Tuberculosis_Homo sapiens_hsa05152 | 1.49290760 |
29 | Malaria_Homo sapiens_hsa05144 | 1.43505470 |
30 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.38243115 |
31 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.37146795 |
32 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.28169882 |
33 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.23042331 |
34 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.17404813 |
35 | Pertussis_Homo sapiens_hsa05133 | 1.14967429 |
36 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.14439343 |
37 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.11883629 |
38 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.10933410 |
39 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.06202946 |
40 | Hepatitis C_Homo sapiens_hsa05160 | 1.02253621 |
41 | Hepatitis B_Homo sapiens_hsa05161 | 1.01521332 |
42 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.95347019 |
43 | Legionellosis_Homo sapiens_hsa05134 | 0.95144952 |
44 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.91730175 |
45 | Platelet activation_Homo sapiens_hsa04611 | 0.90944400 |
46 | Apoptosis_Homo sapiens_hsa04210 | 0.89025375 |
47 | Other glycan degradation_Homo sapiens_hsa00511 | 0.80013455 |
48 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.79658614 |
49 | Shigellosis_Homo sapiens_hsa05131 | 0.72777034 |
50 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.71364200 |
51 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.69452959 |
52 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.68873805 |
53 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.67102852 |
54 | Phagosome_Homo sapiens_hsa04145 | 0.63886638 |
55 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.63371645 |
56 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.61966209 |
57 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.61505297 |
58 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.60682046 |
59 | HTLV-I infection_Homo sapiens_hsa05166 | 0.59965399 |
60 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.59944285 |
61 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.59510921 |
62 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.56434442 |
63 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.50798030 |
64 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.48860990 |
65 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.48644982 |
66 | ABC transporters_Homo sapiens_hsa02010 | 0.47072079 |
67 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.45460366 |
68 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.44389353 |
69 | Insulin resistance_Homo sapiens_hsa04931 | 0.43944533 |
70 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.42070833 |
71 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.41279647 |
72 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.41030011 |
73 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.40628296 |
74 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.40308848 |
75 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.39904251 |
76 | Lysosome_Homo sapiens_hsa04142 | 0.39692284 |
77 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.38868354 |
78 | Salmonella infection_Homo sapiens_hsa05132 | 0.38837002 |
79 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.37970272 |
80 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.37649445 |
81 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.36237368 |
82 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.33670928 |
83 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.33486753 |
84 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.33277450 |
85 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.30604503 |
86 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.28100007 |
87 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.27716723 |
88 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.26441759 |
89 | Endocytosis_Homo sapiens_hsa04144 | 0.25534932 |
90 | Amoebiasis_Homo sapiens_hsa05146 | 0.24622012 |
91 | Prostate cancer_Homo sapiens_hsa05215 | 0.23869405 |
92 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.22498105 |
93 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.21999387 |
94 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.21945528 |
95 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.21759042 |
96 | Renin secretion_Homo sapiens_hsa04924 | 0.20731023 |
97 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.19909694 |
98 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.18816577 |
99 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.17742733 |
100 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.14586175 |